Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies ; day:8 ; month:4 ; year:2021 ; pages:1-14
Cancer immunology immunotherapy ; (8.4.2021), 1-14
- Urheber
-
Bareham, Bethany
Georgakopoulos, Nikitas
Matas-Céspedes, Alba
Curran, Michelle
Saeb-Parsy, Kourosh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-021-02897-5
- URN
-
urn:nbn:de:101:1-2021053012272901771515
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bareham, Bethany
- Georgakopoulos, Nikitas
- Matas-Céspedes, Alba
- Curran, Michelle
- Saeb-Parsy, Kourosh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies
Neurotoxicity of novel cancer immunotherapies
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use
hrHPV E5 oncoprotein: immune evasion and related immunotherapies
Immune biological rationales for the design of combined radio- and immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Application of blood brain barrier models in pre-clinical assessment of glioblastoma-targeting CAR-T based immunotherapies